Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 37

    Strides Pharma arm gets EIR from USFDA for Florida facility

    Strides Pharma arm gets EIR from USFDA for Florida facility

    Medical Dialogues Bureau21 Jan 2020 11:28 AM IST
    The Florida facility is one of the very few manufacturing facilities in the US with a soft gel capsule (SGC) manufacturing suite for formulations...
    Trivitron Healthcare aims over Rs 1000 crore revenue in FY22

    Trivitron Healthcare aims over Rs 1000 crore revenue in FY22

    Medical Dialogues Bureau21 Jan 2020 10:00 AM IST
    "We are looking at a revenue of over Rs 1,000 crore for the fiscal year 2022. It will be achieved through organic and inorganic growth," Trivitron...
    Indian Pharmacopoeia Commission to conduct training program for Drug Regulators, others; invites nominations

    Indian Pharmacopoeia Commission to conduct training program for Drug Regulators, others; invites nominations

    MD bureau20 Jan 2020 2:26 PM IST
    New Delhi: In order to impart training to drugs regulators, drugs analysts and other stakeholders on the issue related to testing, techniques and...
    Biocon chief Kiran Mazumdar Shaw bags Order Of Australia honour

    Biocon chief Kiran Mazumdar Shaw bags Order Of Australia honour

    Medical Dialogues Bureau20 Jan 2020 12:00 PM IST
    Kiran Mazumdar Shaw, Biocon founder and an Australian Global Alumni Ambassador, is also recognised for her sustained and significant contribution to...
    Cipla Patalganga facility gets EIR from USFDA

    Cipla Patalganga facility gets EIR from USFDA

    Farhat Nasim20 Jan 2020 11:52 AM IST
    "Following the inspection by the United States Food and Drug Administration (USFDA) at the Patalganga manufacturing facility of the company from...
    Lupin gets 5 USFDA observations for Vizag facility

    Lupin gets 5 USFDA observations for Vizag facility

    Medical Dialogues Bureau20 Jan 2020 11:24 AM IST
    The inspection for the API facility at Vizag closed with five 483 observations, Lupin said. New Delhi: Drug firm Lupin on Saturday said it has...
    NCB busts drug racket, over 2 lakh Tramadol tablets, cough syrup seized

    NCB busts drug racket, over 2 lakh Tramadol tablets, cough syrup seized

    Medical Dialogues Bureau20 Jan 2020 11:02 AM IST
    New Delhi: The Narcotics Control Bureau(NCB) has unearthed an inter-state racket of psychotropic medicine traffickers with the seizure of over 7 lakh...
    Drugmajors slash prices by 53pc for China bulk-buy program eligibility

    Drugmajors slash prices by 53pc for China bulk-buy program eligibility

    Medical Dialogues Bureau20 Jan 2020 10:00 AM IST
    Beijing: Global pharmaceutical majors and generic drugmakers chopped by 53% on average prices of some of their off-patent products in the latest...
    ProBioGen, Lava Therapeutics ink agreement for Novel Bispecific Molecule

    ProBioGen, Lava Therapeutics ink agreement for Novel Bispecific Molecule

    Medical Dialogues Bureau20 Jan 2020 9:45 AM IST
    New Delhi: ProBioGen AG and Lava Therapeutics B.V. announced the closing of a cell line development and manufacturing agreement for Lava's novel...
    Kala Pharmaceuticals completes Enrollment of STRIDE 3 Trial for EYSUVIS™  for Dry Eye Disease

    Kala Pharmaceuticals completes Enrollment of STRIDE 3 Trial for EYSUVIS™ for Dry Eye Disease

    Medical Dialogues Bureau19 Jan 2020 10:45 AM IST
    Watertown: Kala Pharmaceuticals, Inc. (Kala), a biopharmaceutical company focused on the development and commercialization of therapeutics using its...
    JnJ Collaborates with The MTV Staying Alive Foundation to Launch health campaigns for Indian Youth

    JnJ Collaborates with The MTV Staying Alive Foundation to Launch health campaigns for Indian Youth

    Medical Dialogues Bureau19 Jan 2020 10:00 AM IST
    Mumbai: Johnson & Johnson Services Inc. has announced its collaboration with the internationally acclaimed social change organization The MTV...
    CIMZIA now approved in Canada for the Treatment of Non-Radiographic Axial Spondyloarthritis

    CIMZIA now approved in Canada for the Treatment of Non-Radiographic Axial Spondyloarthritis

    Medical Dialogues Bureau19 Jan 2020 9:45 AM IST
    Oakville: UCB Canada Inc. announced that Health Canada has approved CIMZIA® (certolizumab pegol) for the treatment of adults with severe active...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Aurobindo Pharma faces CA Suit in US for concealing facts

    Aurobindo Pharma faces CA Suit in US for concealing facts

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral...

    Capacit

    Capacit'e Infraprojects bags Rs 407 crore order in Mumbai

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok